Summary

Persistence Market Research has recently released a comprehensive report on the U.S. Pharmaceutical Logistics Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the U.S. pharmaceutical logistics market from 2025 to 2032. The U.S. pharmaceutical logistics market is positioned for steady growth, supported by rising pharmaceutical production, expanding biologics and specialty drugs, and increasing demand for temperature-controlled distribution across the country.

Key Insights:

• U.S. Pharmaceutical Logistics Market Size (2025E): US$ 24.7 Bn
• Projected Market Value (2032F): US$ 43.6 Bn
• U.S. Market Growth Rate (CAGR 2025 to 2032): 8.4%

U.S. Pharmaceutical Logistics Market – Report Scope:

Pharmaceutical logistics plays a critical role in ensuring the safe, timely, and compliant transportation, storage, and distribution of pharmaceutical products across the United States. This market includes a wide range of logistics services such as cold chain management, warehousing, inventory control, packaging, and last-mile delivery for prescription drugs, vaccines, biologics, medical devices, and clinical trial materials. The U.S. pharmaceutical logistics market serves pharmaceutical manufacturers, biotechnology companies, hospitals, retail and specialty pharmacies, and research organizations. Market growth is driven by the increasing complexity of drug formulations, stringent regulatory requirements from agencies such as the FDA, and the growing need for reliable cold chain infrastructure to support temperature-sensitive products.

Market Growth Drivers:

The U.S. pharmaceutical logistics market is propelled by several key factors, including the rapid growth of biologics, biosimilars, and personalized medicines that require specialized handling and cold chain solutions. The increasing prevalence of chronic diseases and the rising consumption of prescription medications further boost demand for efficient pharmaceutical distribution networks. Additionally, the expansion of clinical trials, vaccine programs, and direct-to-patient delivery models is strengthening the role of advanced logistics services. Technological advancements such as real-time tracking, IoT-enabled monitoring, and automated warehousing systems enhance supply chain visibility, safety, and efficiency, contributing significantly to market growth.

Market Restraints:

Despite strong growth prospects, the U.S. pharmaceutical logistics market faces challenges related to high operational costs, regulatory compliance, and infrastructure complexity. Maintaining strict temperature control, particularly for biologics and vaccines, requires significant investment in cold storage facilities and specialized transportation equipment. Regulatory compliance with FDA guidelines, Good Distribution Practices (GDP), and data integrity standards increases the operational burden for logistics providers. Moreover, supply chain disruptions, labor shortages, and rising fuel and transportation costs can impact service reliability and profit margins, posing challenges for market participants.

Market Opportunities:

The U.S. pharmaceutical logistics market presents substantial opportunities driven by innovation, digital transformation, and evolving healthcare delivery models. The growing adoption of cold chain-as-a-service, integrated logistics platforms, and end-to-end supply chain solutions creates new growth avenues for service providers. Expansion of home healthcare and direct-to-consumer pharmaceutical delivery is further enhancing demand for last-mile logistics solutions. Additionally, increased investment in smart warehouses, automation, blockchain for traceability, and AI-driven demand forecasting offers opportunities to improve efficiency and reduce risks. Strategic partnerships between pharmaceutical companies, logistics providers, and technology firms are expected to play a crucial role in shaping the future of the market.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the U.S. pharmaceutical logistics market?

• Which logistics services and temperature-controlled solutions are witnessing the highest demand in the U.S.?
• How are digital technologies and automation transforming pharmaceutical supply chains?
• Who are the key players in the U.S. pharmaceutical logistics market, and what strategies are they adopting to strengthen their market position?
• What are the emerging trends and future prospects in the U.S. pharmaceutical logistics landscape?

Competitive Intelligence and Business Strategy:

Leading players in the U.S. pharmaceutical logistics market focus on service expansion, technological innovation, and strategic collaborations to maintain a competitive edge. Companies invest heavily in cold chain infrastructure, advanced tracking systems, and regulatory-compliant facilities to support high-value and temperature-sensitive pharmaceutical products. Strategic acquisitions, partnerships with pharmaceutical manufacturers, and integration of value-added services such as packaging, labeling, and inventory management are key strategies adopted by market leaders. Emphasis on compliance, reliability, and scalability enables logistics providers to meet the evolving needs of the U.S. pharmaceutical industry.

Key Companies Profiled:

• FedEx Corp.
• Lineage Logistics
• Americold Logistics
• CTW Logistics
• United States Cold Storage (USCS)
• SEKO Logistics
• United Parcel Service Inc.
• Nichirei Logistics Group, Inc.
• C H Robinson Worldwide Inc.
• Owens and Minor Inc.
• Others

Market Segmentation

By Type

• Cold Chain Logistics
• Non-cold Chain Logistics

By Component

• Storage
• Transportation
• Monitoring Components

By Services

• Transport
• Warehousing Services
• Value-added Services

By Zone

• West U.S.
• Midwest U.S.
• Southwest U.S.
• Southeast U.S.
• Northeast U.S.

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. U.S. Pharmaceutical Logistics Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Value Chain Analysis
3.2. Key Market Players
3.3. Regulatory Landscape
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
3.6. Key Development Strategies
3.7. Consumer Behavior Analysis
4. Price Trend Analysis, 2019 - 2032
4.1. Pricing Analysis, By Type
4.2. Key Factors Impacting Service Costs
5. U.S. Pharmaceutical Logistics Market Outlook
5.1. Market Size (US$ Bn) Analysis and Forecast
5.1.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
5.1.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
5.2. U.S. Pharmaceutical Logistics Market Outlook: Type
5.2.1. Historical Market Size (US$ Bn) Analysis, By Type, 2019-2024
5.2.2. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
5.2.2.1. Cold Chain Logistics
5.2.2.2. Non-cold Chain Logistics
5.2.3. Market Attractiveness Analysis: Type
5.3. U.S. Pharmaceutical Logistics Market Outlook: Component
5.3.1. Historical Market Size (US$ Bn) Analysis, By Component, 2019-2024
5.3.2. Market Size (US$ Bn) Analysis and Forecast, By Component, 2025-2032
5.3.2.1. Storage
5.3.2.1.1. Warehouse
5.3.2.1.2. Refrigerated Container
5.3.2.2. Transportation
5.3.2.2.1. Sea Freight Logistics
5.3.2.2.2. Airfreight Logistics
5.3.2.2.3. Overland Logistics
5.3.2.3. Monitoring Components
5.3.2.3.1. Hardware
5.3.2.3.2. Software
5.3.3. Market Attractiveness Analysis: Component
5.4. U.S. Pharmaceutical Logistics Market Outlook: Services
5.4.1. Historical Market Size (US$ Bn) Analysis, By Services, 2019-2024
5.4.2. Market Size (US$ Bn) Analysis and Forecast, By Services, 2025-2032
5.4.2.1. Transport
5.4.2.2. Warehousing Services
5.4.2.3. Value-added Services
5.4.3. Market Attractiveness Analysis: Services
6. U.S. Pharmaceutical Logistics Market Outlook: Zone
6.1. Historical Market Size (US$ Bn) Analysis, By Zone, 2019-2024
6.2. Market Size (US$ Bn) Analysis and Forecast, By Zone, 2025-2032
6.2.1. West U.S.
6.2.2. Midwest U.S.
6.2.3. Southwest U.S
6.2.4. Southeast U.S.
6.2.5. Northeast U.S.
6.3. Market Attractiveness Analysis: Zone
7. Competition Landscape
7.1. Market Share Analysis, 2024
7.2. Market Structure
7.2.1. Competition Intensity Mapping By Market
7.2.2. Competition Dashboard
7.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
7.3.1. FedEx Corp.
7.3.1.1. Overview
7.3.1.2. Segments and Type
7.3.1.3. Key Financials
7.3.1.4. Market Developments
7.3.1.5. Market Strategy
7.3.2. Lineage Logistics
7.3.3. Americold Logistics
7.3.4. CTW Logistics
7.3.5. United States Cold Storage (USCS)
7.3.6. SEKO Logistics
7.3.7. United Parcel Service Inc.
7.3.8. Nichirei Logistics Group, Inc.
7.3.9. C H Robinson Worldwide Inc.
7.3.10. Owens and Minor Inc.
7.3.11. Others
8. Appendix
8.1. Research Methodology
8.2. Research Assumptions
8.3. Acronyms and Abbreviations